Prevenar 13((R)) New Pneumococcal Vaccine for Small Children and Infants

被引：0
|
作者：
Kearns, Anette [1 ]
机构：
[1] Wyeth Lederle Pharma GmbH, Storchengasse 1, A-1150 Vienna, Austria
来源：
PADIATRIE UND PADOLOGIE | 2010年 / 45卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [41] PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
    Chapman, Timothy J.
    Olarte, Liset
    Dbaibo, Ghassan
    Houston, Avril Melissa
    Tamms, Gretchen
    Lupinacci, Robert
    Feemster, Kristen
    Buchwald, Ulrike K.
    Banniettis, Natalie
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 137 - 147
  • [42] COST-EFFECTIVENESS OF PREVENAR 13 IN CHILDREN IN PORTUGAL
    Fiorentino, F.
    Gouveia, M.
    Jesus, G.
    Costa, J.
    Borges, M.
    VALUE IN HEALTH, 2016, 19 (07) : A415 - A415
  • [43] Serotype 19F pneumococcal meningitis in an imunocompetent infant immunized with heptavalent pneumococcal conjugated vaccine Prevenar®
    Isapof, A.
    Delacourt, C.
    Reinert, P.
    Cohen, R.
    Madhi, F.
    ARCHIVES DE PEDIATRIE, 2009, 16 (08): : 1133 - 1136
  • [44] PNEUMOCOCCAL VACCINE IN CHILDREN
    GRANOFF, DM
    CLINICAL PEDIATRICS, 1980, 19 (02) : 96 - 100
  • [45] Policy Statement-Recommendations for the Prevention of Streptococcus pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)
    Bocchini, Joseph A., Jr.
    Bradley, John S.
    Brady, Michael T.
    Bernstein, Henry H.
    Byington, Carrie L.
    Fisher, Margaret C.
    Glode, Mary P.
    Jackson, Mary Anne
    Keyserling, Harry L.
    Kimberlin, David W.
    Orenstein, Walter A.
    Schutze, Gordon E.
    Willoughby, Rodney E., Jr.
    PEDIATRICS, 2010, 126 (01) : 186 - 190
  • [46] Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults
    Gladstone, Rebecca A.
    Jefferies, Johanna M.
    Faust, Saul N.
    Clarke, Stuart C.
    EXPERT REVIEW OF VACCINES, 2012, 11 (08) : 889 - 902
  • [47] PNEUMOCOCCAL SEROTYPES CAUSING PNEUMONIA IN THE 13 VALENT PNEUMOCOCCAL CONJUGATE VACCINE ERA IN AUSTRALIAN CHILDREN
    Strachan, R.
    Gilbert, G.
    Homaira, N.
    Oftadeh, S.
    Snelling, T.
    Jaffe, A.
    RESPIROLOGY, 2020, 25 : 86 - 86
  • [48] Pneumococcal serotypes causing pneumonia in the 13 valent pneumococcal conjugate vaccine era in Australian children
    Strachan, R.
    Gilbert, L.
    Homaira, N.
    Oftadeh, S.
    Snelling, T.
    Jaffe, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 134 - 135
  • [49] Immunogenicity of conjugate pneumococcal vaccine (Prevenar) in ataxia telangiectasia: evidence of a genotype/phenotype correlation
    Davies, E. G.
    Ashton, L.
    Mcdermott, E.
    Core, C.
    Taylor, A. M. R.
    Goldblatt, D.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 : 115 - 116
  • [50] 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Preterm Versus Term Infants
    Martinon-Torres, Federico
    Czajka, Hanna
    Center, Kimberly J.
    Wysocki, Jacek
    Majda-Stanislawska, Ewa
    Omenaca, Felix
    Bernaola Iturbe, Enrique
    Blazquez Gamero, Daniel
    Concheiro-Guisan, Ana
    Gimenez-Sanchez, Francisco
    Szenborn, Leszek
    Giardina, Peter C.
    Patterson, Scott
    Gruber, William C.
    Scott, Daniel A.
    Gurtman, Alejandra
    PEDIATRICS, 2015, 135 (04) : E876 - E886
12345